Changelog
RSSMost-recently-updated content across the BestHealingPeptides library. Items are sorted by the page’s dateModified stamp.
For laboratory and research use only — not for human consumption.
- Research summaryUK research peptide regulation in 2026 — a reference guide
The UK regulatory position on research peptides sits across four distinct frameworks — MHRA medicines licensing, WADA anti-doping classifications, the Misuse of Drugs Act, and the Human Medicines Regulations 2012. This reference explains how each applies, and what the research-versus-supply distinction means in practice.
- PeptideBPC-157
A 15-amino-acid pentadecapeptide derived from a protective protein found in human gastric juice. The most-studied healing research peptide, with extensive pre-clinical work on tendon, ligament, gut, and vascular repair.
- PeptideTB-500
A synthetic peptide commonly described as a fragment of thymosin beta-4 incorporating the actin-binding 'LKKTETQ' motif. Studied for soft-tissue repair, wound healing, and cardiac tissue regeneration in animal models.
- PeptideGHK-Cu
A naturally occurring copper-binding tripeptide (Gly-His-Lys) complexed with Cu(II). Extensively studied in dermatology for wound healing, collagen synthesis, antioxidant defence, and hair-follicle stimulation.
- PeptideThymosin Beta-4
A 43-amino-acid actin-sequestering peptide expressed in nearly all human cells. Distinct from the shorter TB-500 fragment; investigated in cardiac repair, corneal healing, neural regeneration, and dermal regeneration.
- PeptidePentosan Polysulfate
A semi-synthetic sulfated polysaccharide investigated in osteoarthritis, interstitial cystitis, and connective-tissue research for its chondroprotective, anti-inflammatory, and anticoagulant effects — with a critical long-term safety signal regarding pigmentary maculopathy.
- PeptideKPV
A three-amino-acid C-terminal fragment of α-MSH studied for its anti-inflammatory effects in colitis, atopic skin conditions, and mucosal healing models — without the pigmentary effects of full-length MSH.
- PeptideLL-37
The only human cathelicidin antimicrobial peptide — a 37-residue cationic amphipathic helix studied for direct antimicrobial action, wound healing, angiogenesis, and dual-edged modulation of host innate immune responses.
- PeptideAOD-9604
A 16-amino-acid C-terminal analogue of human growth hormone, originally investigated for lipolytic activity without IGF-1 effects, and subsequently studied for cartilage repair and post-injury recovery.
- PeptideAC-SDKP (TB-500 Fragment)
A naturally occurring N-terminal tetrapeptide released from thymosin beta-4 by prolyl oligopeptidase. AC-SDKP circulates endogenously, is rapidly degraded by angiotensin-converting enzyme (ACE), and is studied primarily for anti-fibrotic, pro-angiogenic, and haematopoietic regulatory effects across cardiac, renal, and pulmonary tissue.
- PeptideEpitalon
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) modelled on the bovine pineal extract epithalamin. Investigated primarily in Russian gerontology research for effects on telomerase activity in cultured somatic cells, circadian rhythm normalisation in aged animals, and antioxidant defence. Evidence is largely confined to one research network and independent replication is limited.
- PeptideLarazotide
An eight-amino-acid synthetic peptide functioning as a tight-junction regulator and zonulin antagonist. Designed for luminal delivery with minimal systemic absorption, larazotide has been investigated in multiple Phase II trials for coeliac disease with persistent symptoms, and represents the furthest-advanced clinical programme for a peptide targeting intestinal barrier function.
- ComparisonBPC-157 vs TB-500
BPC-157 and TB-500 are the two most-discussed research peptides in soft-tissue repair. They have overlapping interest areas — tendon, ligament, and vascular healing — but operate by different mechanis
- ComparisonGHK-Cu vs TB-500
GHK-Cu and TB-500 are sometimes grouped together as 'tissue-repair peptides', but the two operate at very different scales — GHK-Cu primarily as a transcriptional modulator of dermal fibroblasts, TB-5
- ComparisonKPV vs LL-37
KPV and LL-37 occupy overlapping but distinct niches in the inflammation–antimicrobial peptide space. KPV is small, charge-neutral, and primarily anti-inflammatory; LL-37 is larger, cationic, and comb
- ComparisonBPC-157 vs AOD-9604
Both BPC-157 and AOD-9604 are discussed in the context of post-injury recovery, but they originate from very different research programmes and target different tissues.
- StackTendon & Ligament Research Stack
Combine peptides studied for soft-tissue, vascular, and cellular-migration effects in tendon and ligament repair research.
- StackGut Healing Research Stack
Examine complementary effects on mucosal repair, inflammatory cytokine release, and tight-junction integrity in pre-clinical gut models.
- StackSkin & Wound Healing Research Stack
Address dermal collagen synthesis, angiogenesis, and antimicrobial defence in pre-clinical wound-healing models.
- Research summaryBPC-157 in tendon healing — what the 2024 evidence base shows
Across more than two dozen rodent studies, BPC-157 has consistently improved biomechanical recovery, collagen organisation, and tenocyte migration after experimental tendon injury. Translation to human work remains unproven.
- Research summaryGHK-Cu and skin regeneration — what the dermal evidence shows
GHK-Cu has the strongest dermal evidence base of any non-prescription peptide ingredient — supported by gene-expression studies, in-vivo wound-healing models, and decades of topical cosmetic use.
- Research summaryBest healing peptides for research in 2026
BPC-157 remains the most-studied research peptide for soft-tissue repair; GHK-Cu leads dermal regeneration; KPV and larazotide dominate gut-barrier research; LL-37 sits at the antimicrobial-host-defence intersection.
- Injury hubPeptides studied for rotator cuff repair research
Rotator cuff injury — tears of the supraspinatus, infraspinatus, subscapularis, or teres minor — has limited natural healing capacity, which has driven sustained pre-clinical interest in peptides that influence tenocyte migration, collagen synthesis, and peritendinous angiogenesis.
- Injury hubPeptides studied for Achilles tendinopathy research
Achilles tendinopathy is the most extensively modelled tendon condition in peptide research, with Krivic and colleagues' 2010 rat transection paper providing the canonical BPC-157 dataset.
- Injury hubPeptides studied for plantar fasciitis research
Plantar fasciitis sits at the boundary of tendinopathy and enthesopathy research, with overlapping peptide interest in collagen organisation and connective-tissue remodelling.
- Injury hubPeptides studied for MCL and ACL injury research
Ligament injury has limited spontaneous healing capacity, particularly the intra-articular ACL. Pre-clinical peptide research focuses on fibroblast migration, neovascularisation, and matrix remodelling.
- Injury hubPeptides studied for irritable bowel syndrome research
IBS research increasingly focuses on gut-barrier integrity, low-grade inflammation, and microbial signalling — three domains in which research peptides have established pre-clinical activity.
- Injury hubPeptides studied for Crohn's disease research
Crohn's disease research peptides target transmural inflammation, mucosal healing, and intestinal barrier dysfunction — with KPV's NF-κB-pathway suppression and BPC-157's mucosal angiogenesis effects as the principal pre-clinical hypotheses.
- Injury hubPeptides studied for diabetic wound healing research
Diabetic wound healing is one of the most-studied research applications for GHK-Cu and other regenerative peptides, with impaired angiogenesis and chronic low-grade inflammation as the principal mechanistic targets.
- Injury hubPeptides studied for pressure-sore healing research
Pressure-ulcer research peptides target the chronic inflammatory and microvascular dysfunction that characterise stage III and IV wounds, with GHK-Cu and LL-37 as the leading research candidates.
- Injury hubPeptides studied for burn healing research
Burn healing research peptides target re-epithelialisation rate, microvascular regeneration, and scar quality — with GHK-Cu and LL-37 contributing antimicrobial and pro-regenerative effects relevant to partial-thickness burns.
- Injury hubPeptides studied for post-surgical recovery research
Post-surgical recovery research peptides target anastomotic integrity, wound dehiscence prevention, and accelerated functional return. BPC-157 has the deepest pre-clinical anastomotic-healing dataset of any research peptide.
- RankingBest healing peptides for tendon & ligament research (UK 2026)
Ranked reference of the most-studied research peptides for tendon and ligament repair: BPC-157, TB-500, thymosin beta-4, AC-SDKP. UK laboratory use only.
- RankingBest healing peptides for gut research (UK 2026)
Ranked reference of research peptides studied for gut healing, intestinal barrier integrity, and IBD: BPC-157, KPV, larazotide.
- RankingBest healing peptides for skin & wound research (UK 2026)
Ranked reference of research peptides studied for dermal regeneration, wound closure, and antimicrobial defence: GHK-Cu, LL-37, BPC-157, thymosin beta-4.
- RankingBest anti-inflammatory research peptides (UK 2026)
Ranked reference of research peptides studied for cytokine suppression, NF-κB modulation, and anti-fibrotic effects: KPV, BPC-157, AC-SDKP, GHK-Cu, pentosan polysulfate.
- RankingBest peptides for post-injury recovery research (UK 2026)
Ranked reference of research peptides studied for post-traumatic and post-surgical recovery: BPC-157, TB-500, AOD-9604, GHK-Cu, thymosin beta-4.
- Mechanism hubAngiogenesis: research peptides that promote new blood-vessel formation
Angiogenesis — the formation of new blood vessels from pre-existing vasculature — is a central mechanism in tissue repair. Several research peptides modulate angiogenic signalling through distinct pathways.
- Mechanism hubAnti-fibrotic research peptides: TGF-β suppression and matrix remodelling
Anti-fibrotic research peptides target the TGF-β–Smad signalling axis, fibroblast-to-myofibroblast transition, and excessive collagen-III deposition — three drivers of pathological scarring.
- Mechanism hubActin-binding research peptides: thymosin beta-4 and the LKKTETQ motif
Actin-binding research peptides sequester G-actin monomers, maintaining the intracellular pool from which actin filaments assemble during cell migration and remodelling.
- Mechanism hubAntimicrobial research peptides: cationic membrane disruption
Antimicrobial research peptides are typically cationic amphipathic helices that insert into anionic microbial membranes, disrupting bilayer integrity while modulating host innate-immune responses.
- Mechanism hubTight-junction modulation: zonulin antagonism and gut barrier research
Tight-junction modulation is a focused research mechanism most associated with larazotide, which antagonises zonulin signalling at the apical surface of intestinal epithelial cells.
- GlossaryAngiogenesis
The formation of new blood vessels from pre-existing vasculature.
- GlossaryFibroblast
Connective-tissue cell that synthesises collagen and the extracellular matrix.
- GlossaryMMP (Matrix metalloproteinase)
Matrix metalloproteinase — zinc-dependent enzyme that remodels the extracellular matrix.
- GlossaryNF-κB
Nuclear factor kappa B — a transcription factor central to inflammatory gene expression.
- GlossaryLyophilisation
Freeze-drying process used to stabilise peptides as a dry powder.
- GlossaryTight junction
Cell-cell adhesion complex regulating paracellular transport in epithelia.
- GlossaryVEGF
Vascular endothelial growth factor — signals new blood-vessel formation.
- GlossaryTenocyte
Specialised fibroblast forming the cellular component of tendons.
- GlossaryCollagen
The most abundant structural protein in the body, organised into types with distinct tissue roles.
- GlossaryHalf-life
Time for the plasma concentration of a substance to fall to half its initial value.
- GlossaryBioavailability
Fraction of an administered dose that reaches systemic circulation in unchanged form.
- GlossaryEndotoxin
Bacterial lipopolysaccharide that triggers TLR4-mediated inflammation; a critical research-peptide quality control parameter.
- GlossaryLAL test
Limulus amebocyte lysate assay — the standard method for quantifying bacterial endotoxin contamination.
- GlossaryCertificate of Analysis (CoA)
Batch-specific document reporting purity, identity, and contaminant results for a research peptide lot.
- GlossaryHPLC
High-performance liquid chromatography — the principal method for assessing peptide purity.
- GlossaryZonulin
Endogenous protein that regulates intestinal tight-junction permeability and the molecular target of larazotide.
- GlossaryWADA Prohibited List
Annual list published by the World Anti-Doping Agency classifying substances and methods banned in sport.
- GlossaryMHRA
UK Medicines and Healthcare products Regulatory Agency — licenses medicines for UK use.
- GlossaryReconstitution
Dissolving a lyophilised peptide in an appropriate aqueous vehicle prior to research use.
- GlossaryBacteriostatic water
Sterile water containing 0.9% benzyl alcohol as a bacteriostatic preservative — the standard peptide reconstitution vehicle.